Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/4560
Title: New stability indicating chromatographic methods for desloratadine, clopidogrel, duloxetine, ibuprofen, diphenhydramine, losartan, atenolol and hydrochlorothiazide drugs
Researcher: Rao, Dantu Durga
Guide(s): Sait, Shakil S
Keywords: desloratadine drugs
clopidogrel drugs
duloxetine drugs
ibuprofen drugs
diphenhydramine drugs
losartan drugs
atenolol drugs
hydrochlorothiazide drugs
Upload Date: 5-Sep-2012
University: Jawaharlal Nehru Technological University
Completed Date: March, 2012
Abstract: In this thesis we provide new analytical methodologies UPLC/HPLC that can be improves the analysis throughput and cycle times. The proficient research work has been divided in to six chapters, The thesis is composed of five articles, eight active pharmaceutical ingredient (API) and five of their dosage forms were selected for the research work, keeping objective to develop a new stability indicating analytical methods for the determination of assay and related components which are stability indicating analytical methods. After through literature survey reveals that no stability indicating methods for determining the related process bi-products / impurities in the above mentioned eight selected API?s, its precursors and their dosage forms were available as on date, very few methods appeared in the literature for the determination of human plasma, Urine, LCMS/MS etc. Suitable new, simple, cost effective (user friendly) and stability indicating analytical methods were developed, keeping the current regulatory requirements in mind and the developed methods were extensively validated. The developed new analytical methods were performed well for the quality evolution of stability samples of API and its procuresses.The first chapter consists of a brief introduction on the need for development of new analytical methods for related components estimation, source of impurities in pharmaceutical substances, requirement for control of impurities, ICH quality guidelines,pharmacopeial norms, control of organic impurities, FDA recommendations, approaches for development of stability indicating methods with LC contents of method validation parameters and discussion on how to develop a new method approaches on the general methodology for LC (HPLC/UPLC) analysis. The remaining chapter 2-6 consists of Introduction, experimental, validation and results and discussion. In the introduction part a brief account on the therapeutic activity, drug molecule and need to developing new method development were discussed.
Pagination: 248p.
URI: http://hdl.handle.net/10603/4560
Appears in Departments:Faculty of Chemistry

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File106.02 kBAdobe PDFView/Open
02_dedication.pdf102.33 kBAdobe PDFView/Open
03_declaration.pdf111.96 kBAdobe PDFView/Open
04_certificates.pdf129.21 kBAdobe PDFView/Open
05_acknowledgements.pdf113.15 kBAdobe PDFView/Open
06_abstract.pdf84.66 kBAdobe PDFView/Open
07_contents.pdf139.41 kBAdobe PDFView/Open
08_list of tables.pdf185.58 kBAdobe PDFView/Open
09_list of figures.pdf230.54 kBAdobe PDFView/Open
10_abbreviations.pdf113.53 kBAdobe PDFView/Open
11_chapter 1.pdf594.6 kBAdobe PDFView/Open
12_chapter 2.pdf724.24 kBAdobe PDFView/Open
13_chapter 3.pdf1.03 MBAdobe PDFView/Open
14_chapter 4.pdf679.09 kBAdobe PDFView/Open
15_chapter 5.pdf1.02 MBAdobe PDFView/Open
16_chapter 6.pdf895.95 kBAdobe PDFView/Open
17_chapter 7.pdf294.4 kBAdobe PDFView/Open


Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.